Log In
Print
BCIQ
Print
Print this Print this
 

Lotemax, loteprednol etabonate

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionTopical 0.5% steroid
Molecular Target Corticoid receptors
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today